Real-world safety of linaclotide in Chinese patients with irritable bowel syndrome with constipation: a multicenter, single-arm, prospective observational study
Background: Linaclotide, a guanylate cyclase-C agonist, is indicated for irritable bowel syndrome with constipation (IBS-C). However, real-world data on the safety and patient-reported outcomes (PROs) of linaclotide are scarce in Chinese patients with IBS-C. Objectives: To assess the real-world safe...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publishing
2025-02-01
|
| 叢編: | Therapeutic Advances in Gastroenterology |
| 在線閱讀: | https://doi.org/10.1177/17562848251314819 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|